Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk

Annals of Neurology

Volumn 48, Issue 3, 2000, Pages 388-391

  Licastro, Federico ^a,e   Pedrini, Steve ^a   Ferri, Cinzia ^b   Casadei, Valeria ^b   Govoni, Marzia ^a   Pession, Annalisa ^a   Sciacca, Francesca Luisa ^b   Veglia, Fabrizio ^b   Annoni, Giorgio ^c   Bonafè, Massimiliano ^a   Olivieri, Fabiola ^d   Franceschi, Claudio ^d   Grimaldi, Luigi Maria Edoardo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d INRCA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; INTERLEUKIN 1; SERINE PROTEINASE INHIBITOR;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC ACTIVATION; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; GENOTYPE; HUMANS; INTERLEUKIN-1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0033848463     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200009)48:3<388::AID-ANA16>3.0.CO;2-G     Document Type: Article

References (20)

1. Medical progress: Alzheimer's disease
2. The genetics of Alzheimer's disease
3. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
4. Apolipoprotein E polymorphism and Alzheimer's disease
5. Patterns of gliosis in Alzheimer's disease and aging cerebrum
6. Neuroimmune mechanisms in Alzheimer's disease pathogenesis
7. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
8. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease
9. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits
10. A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer disease
11. 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B
12. Inverse association of anti-inflammatory treatments and Alzheimer's disease
13. Blood levels of histamine, IL-1β and TNF-α in patients with mild to moderate Alzheimer disease
14. Increased serum α-1-antichymotrypsin in patients with probable Alzheimer's disease: An acute phase reactant without the peripheral acute phase response
15. Association of early onset Alzheimer's disease with an interleukin-1α gene polymorphism
16. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
17. Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain?
18. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
19. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype